ÖZKAN, M. Et Al. 2018. Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib. ASCO .

ÖZKAN, M., DOĞAN, E., CANÖZ, Ö., BOZKURT, O., & İNANÇ, M., (2018). Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib . ASCO

ÖZKAN, METİN Et Al. "Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib," ASCO, 2018

ÖZKAN, METİN Et Al. "Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib." ASCO , 2018

ÖZKAN, M. Et Al. (2018) . "Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib." ASCO .

@conferencepaper{conferencepaper, author={METİN ÖZKAN Et Al. }, title={Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib}, congress name={ASCO}, city={}, country={}, year={2018}}